Human complement in thrombin-mediated platelet function: uptake of the C5b-9 complex.
Thrombin-mediated platelet aggregation and release is enhanced by the presence of C3, C5, C6, C7, C8, and C9 of human complement. The interaction of thrombin with its receptor on the platelet membrane initiates activation of complement on the platelet surface. Trypsin-mediated platelet function is not enhanced by the addition of complement, probably because trypsin has no receptor on the platelet surface so activation of complement is triggered in the fluid phase and not on the platelet surface. Activation of complement by thrombin led to production of dimers of the C5b-9 complex on the platelet surface. These complexes were eluted from the platelet membrane and were identified physicochemically and morphologically. The mechanism of complement-induced enhancement of platelet function is not clear, however, it probably is mediated via the arachidonic acid transormation pathway because this activity was blocked by known inhibitors of cyclo-oxygenase, namely, aspirin and indomethacin.
D000990:Antithrombin III / Q000502:physiology; D001241:Aspirin / Q000494:pharmacology; D001792:Blood Platelets / Q000502:physiology*; D003182:Complement C5 / Q000378:metabolism*; D003186:Complement C9 / Q000378:metabolism*; D003165:Complement System Proteins / Q000502:physiology*; D006801:Humans; D066298:In Vitro Techniques; D010974:Platelet Aggregation / Q000187:drug effects; D012701:Serotonin / Q000378:metabolism; D013917:Thrombin / Q000494:pharmacology*; D014357:Trypsin / Q000494:pharmacology
D003182:Complement C5; D003186:Complement C9; D012701:Serotonin; D000990:Antithrombin III; D003165:Complement System Proteins; D014357:Trypsin; D013917:Thrombin; D001241:Aspirin